Making it happen: Development of an interprofessional deprescribing education programme
Basic & Clinical Pharmacology & Toxicology · 2024
DOI: 10.1111/bcpt.13950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2024. Verfasst von Natalie Kennie-Kaulbach und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada. Hauptthemen laut MEDLINE: Deprescriptions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dalhousie Pharmacy Endowment Fund, Drug Evaluation Alliance of Nova Scotia, College of Pharmacy, Dalhousie University.
Abstract (Originalsprache)
Deprescribing is the planned and supervised reduction or discontinuation of medications that may be causing harm or are no longer benefiting a patient. The need for deprescribing to be a routine part of patient care is essential with an aging population and the rising prevalence of polypharmacy, which has been associated with increased adverse outcomes such as falls, hospitalizations and mortality. Deprescribing is a complex intervention that requires collaboration between the patient, caregivers and healthcare providers to adequately support all involved, as well as to ensure medications are not restarted in error. The objective of this article is to describe the stepwise approach to planning and ongoing development of an online, interprofessional deprescribing education programme for healthcare providers and students with the goal of enhancing deprescribing practice. There were four main planning and development components: (1) a needs assessment to provide guidance on programme design, development and delivery; (2) a consultative programme planning process with an advisory group of stakeholders and patient partners to inform programme learning outcomes and content; (3) a core development team for the creation of programme content; and (4) planning for programme evaluation. Based on the stepwise and consultative process, programme outcomes were identified, and five modules were developed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada.
ORCID-Profile: Natalie Kennie-Kaulbach, Hannah Gormley, Jennifer E Isenor
Förderung
- Dalhousie Pharmacy Endowment Fund
- Drug Evaluation Alliance of Nova Scotia
- College of Pharmacy, Dalhousie University
Zitieren
APA
Kennie-Kaulbach, N., Ramsay, E., Gormley, H., & Isenor, J. E. (2024). Making it happen: Development of an interprofessional deprescribing education programme. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.13950
Vancouver
Kennie-Kaulbach N, Ramsay E, Gormley H, Isenor JE. Making it happen: Development of an interprofessional deprescribing education programme. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.13950
BibTeX
@article{KennieKaulbach2024,
author = {Kennie-Kaulbach, Natalie and Ramsay, Emma and Gormley, Hannah and Isenor, Jennifer E},
title = {Making it happen: Development of an interprofessional deprescribing education programme},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2024},
doi = {10.1111/bcpt.13950}
}
EUVIMED